| scholarly article | Q13442814 |
| P50 | author | Mary A. Whooley | Q56332432 |
| Joachim H. Ix | Q87220141 | ||
| Michael G Shlipak | Q87224063 | ||
| Ruth F Dubin | Q90584372 | ||
| P2093 | author name string | Carmen A Peralta | |
| Yongmei Li | |||
| P2860 | cites work | Pentraxins and atherosclerosis: the role of PTX3. | Q37827889 |
| Cystatin C and mortality risk in the elderly: the health, aging, and body composition study | Q40375333 | ||
| Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo | Q43905775 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction | Q48395268 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies | Q57154327 | ||
| Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction | Q83395035 | ||
| Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 | ||
| Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD | Q24652643 | ||
| Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study | Q24654287 | ||
| The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2 | Q28118397 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | Q28257707 | ||
| C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study | Q30763122 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes | Q34751855 | ||
| Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic | Q35040738 | ||
| Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis | Q35133148 | ||
| Evidence for increased cardiovascular disease risk in patients with chronic kidney disease | Q35748410 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| Relations of measures of endothelial function and kidney disease: the Framingham Heart Study | Q37150714 | ||
| Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease | Q37180120 | ||
| Depressive symptoms and health-related quality of life: the Heart and Soul Study | Q37419710 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| circulatory system | Q11068 | ||
| heart disease | Q190805 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 274-279 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | |
| P478 | volume | 163 |
| Q36420463 | Analysis of Clinically Relevant Factors for Pulmonary Hypertension in Maintenance Hemodialysis Patients. |
| Q36533057 | Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly |
| Q33748025 | Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis |
| Q38084920 | Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease |
| Q47813656 | C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques |
| Q26991726 | Cardiac biomarkers: new tools for heart failure management |
| Q100516704 | Cardiovascular prognosis: a new role for ceramides and other cardiometabolites |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q40865321 | Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function |
| Q33744933 | Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial. |
| Q34713240 | Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. |
| Q37115819 | Emerging families of biomarkers for coronary artery disease: inflammatory mediators |
| Q37370584 | Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population |
| Q49942926 | Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases |
| Q44605195 | Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica |
| Q46237239 | Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss |
| Q37629231 | Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients |
| Q51595971 | Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study. |
| Q50143105 | PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer |
| Q39252622 | Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease. |
| Q38901060 | Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation |
| Q45110914 | Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting |
| Q38991073 | Pentraxins in the activation and regulation of innate immunity |
| Q40151204 | Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway |
| Q35140370 | Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial |
| Q38386941 | Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients |
| Q48293075 | Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease |
| Q52761490 | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. |
| Q33760848 | Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study |
| Q34579101 | Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis |
| Q26738957 | The inflammatory protein Pentraxin 3 in cardiovascular disease |
| Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
Search more.